← Leaderboards
Prediman Krishan Shah
Cedars-Sinai Medical Center
$8,075,140
Attributed
$8,887,640
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,887,640 · 6
By mechanism
R01$8,193,394 · 5
P01$694,246 · 1
Top collaborators
- Behrooz G Sharifi4 shared
Most similar at Cedars-Sinai Medical Center
Same institution · by research overlap
- Behrooz G Sharifi$2,800,611
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingIn VivoInsightMacrophageIn VitroCellsInflammationPhenotypeResponseBone Marrow TransplantationInflammatoryMyocardial InfarctionBaseCardiovascular DiseasesSignal TransductionAtherosclerosisChronicArterial Fatty StreakSiteMonocyteEndothelial CellsMolecularInjuryBlood Vessels
Grant awards (20)
A hypercholesterolemia-induced immunometabolite in atherosclerosis$593,363
R01 · FY2025 · HL · contact PI
The role of GATA3-positive macrophages in cardiovascular pathologies$417,500
R01 · FY2025 · HL · contact PI
A hypercholesterolemia-induced immunometabolite in atherosclerosis$595,698
R01 · FY2024 · HL · contact PI
The role of GATA3-positive macrophages in cardiovascular pathologies$417,500
R01 · FY2024 · HL · contact PI
A hypercholesterolemia-induced immunometabolite in atherosclerosis$616,205
R01 · FY2023 · HL · contact PI
The role of GATA3-positive macrophages in cardiovascular pathologies$417,500
R01 · FY2023 · HL · contact PI
A hypercholesterolemia-induced immunometabolite in atherosclerosis$694,138
R01 · FY2022 · HL · contact PI
The role of GATA3-positive macrophages in cardiovascular pathologies$417,500
R01 · FY2022 · HL · contact PI
PTN FUNCTION IN INTIMAL THICKENING$409,150
R01 · FY2014 · HL · contact PI
PTN FUNCTION IN INTIMAL THICKENING$397,460
R01 · FY2013 · HL · contact PI
PTN FUNCTION IN INTIMAL THICKENING$417,500
R01 · FY2012 · HL · contact PI
PTN FUNCTION IN INTIMAL THICKENING$417,500
R01 · FY2011 · HL · contact PI
Directed Vascular Graft Regeneration in Peritoneal Cavity$406,250
R01 · FY2011 · HL · contact PI
Directed Vascular Graft Regeneration in Peritoneal Cavity$406,250
R01 · FY2010 · HL · contact PI
Directed Vascular Graft Regeneration in Peritoneal Cavity$406,250
R01 · FY2009 · HL · contact PI
The Role of Tenascin in Neointimal Formation$378,690
R01 · FY2009 · HL · contact PI
Directed Vascular Graft Regeneration in the Mouse Peritoneal Cavity$406,250
R01 · FY2008 · HL
The Role of Tenascin in Neointimal Formation$378,690
R01 · FY2008 · HL · contact PI
AAV MEDIATED APO A1 GENE THERAPY FOR ATHEROSCLEROSIS$347,123
P01 · FY2002 · HL
AAV MEDIATED APO A1 GENE THERAPY FOR ATHEROSCLEROSIS$347,123
P01 · FY2000 · HL